Inventor · disambiguated record
Oliver Pohl
Also filed as: POHL OLIVER
7 granted patents·9 pending applications·14 citations·filing 2013–2023
80Inventor score
Top patents by PatentIndex Score
16 records- 0185US10555934B2Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2017·Granted Feb 11, 2020·4 cites·60 claims
- 0284US11419851B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2019·Granted Aug 23, 2022·1 cites·6 claims
- 0383US10478420B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2018·Granted Nov 19, 2019·3 cites·6 claims
- 0483US9962367B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2014·Granted May 8, 2018·5 cites·3 claims
- 0581US11759464B2Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood lossObsEva SA·Filed 2018·Granted Sep 19, 2023·1 cites·15 claims
- 0677US2023226021A1Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2022·Application pending·0 cites
- 0774US2023321052A1Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2022·Application pending·0 cites
- 0872US2024000785A1Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood lossKISSEI PHARMACEUTICAL·Filed 2023·Application pending·0 cites
- 0969US11534428B1Compositions and methods for delaying the incidence of laborObsEva SA·Filed 2019·Granted Dec 27, 2022·0 cites·11 claims
- 1069US11524003B2Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereofObsEva SA·Filed 2020·Granted Dec 13, 2022·0 cites·20 claims
- 1169US2023372306A1Compositions and methods for delaying the incidence of laborXOMA US LLC·Filed 2022·Application pending·0 cites
- 1255US2023102503A1Biomarkers for oxytocin receptor antagonist therapyObsEva SA·Filed 2021·Application pending·0 cites
- 1349US2022323410A1Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriageObsEva SA·Filed 2020·Application pending·0 cites
- 1445US2023067378A1Compositions and methods for the treatment of estrogen-dependent disordersObsEva SA·Filed 2019·Application pending·0 cites
- 1540US2015065470A1Steroid Sulfatase Inhibitor Regimen for the Treatment of EndometriosisPREGLEM SA·Filed 2013·Application pending·0 cites
- 1640US2015209373A1Progesterone Receptor Modulators for Use in Preventing or Treating Androgen Mediated DiseasesPREGLEM SA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oliver Pohl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →